The direct-to-consumer genetic testing market size was valued at US$ 1,715.84 million in 2022 and is expected to reach US$ 7,191.68 million by 2030. It is estimated to register a CAGR of 19.6% from 2022 to 2030.
The increasing incidence of genetic disorders and rising public awareness of direct-to-consumer genetic testing are likely to remain the direct-to-consumer genetic testing market trend.
According to the Gimjournal, most prevalence estimates tend to be disease specific, precluding an examination of genetic conditions in the pediatric population overall. An estimated 3.5% to 5.9% of individuals worldwide have 1 of approximately 7000 rare or genetic conditions. According to the Texas.gov, as of 2024, 1 in 22 people in the United States has a genetic disorder. 20-30% of all infant deaths are due to genetic disorders. Direct-to-consumer genetic testing promotes awareness of genetic diseases. It provides personalized information about health, disease risk, and other similar traits. Thus, the rising number of genetic diseases across the globe is expected to drive the global direct-to-consumer genetic testing market
The increasing incidence of genetic disorders and rising public awareness of direct-to-consumer genetic testing are driving the demand for direct-to-consumer genetic testing products. However, DTC genetic testing often does not provide appropriate/conclusive results on whether the consumer will develop a disease or not which is one of the factors that are critically impacting the growth of the direct-to-consumer genetic testing market.
Genetic disorders might impact cognitive development, leading to learning impairments or intellectual disabilities. Raising awareness of genetic disorders is not only about understanding the scientific aspects of such conditions but also about embracing the individuals and families who navigate life with them. According to the National Institutes of Health (NIH), the awareness level of genetic disease is 29.5%. Education is needed for the public about the predisposition, management, and inheritance of genetic diseases. Thus, rising public awareness across the globe is thereby contributing to the direct-to-consumer genetic testing market growth.
In July 2023, Quest Diagnostics, one of the US-based diagnostic information service providers, launched its first consumer-focused genetic test named Genetic Insights. The concerned service will help people in understanding the risks of developing inheritable medical conditions. The service will also include personalized health reports and access to genetic counseling which is a service not commonly offered with similar services. Such a factor is responsible for the growth of the direct-to-consumer genetic testing market size.
Key segments that contributed to the derivation of the Direct-To-Consumer Genetic Testing market analysis are test type and distribution channel.
The geographic scope of the direct-to-consumer genetic testing market report is mainly segmented into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South America/South & Central America.
Based on geography, the direct-to-consumer genetic testing market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The North America, direct-to-consumer genetic testing market has been analyzed based on three major countries — the US, Canada, and Mexico. The North America market held the largest share in 2023 and is expected to continue a similar trend during the forecast period. The US direct-to-consumer genetic testing market is estimated to hold the largest market share during the forecast period. The cost of DTC genetic testing varies from company to company but is roughly in the range of 100–1,000 US dollars, and DTC genetic testing is generally not covered by insurance. Rising expenditures in healthcare applications is further expected to boost the regional market growth during the forecast period.
The regional trends and factors influencing the Direct-To-Consumer Genetic Testing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Direct-To-Consumer Genetic Testing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,715.84 Million |
| Market Size by 2030 | US$ 7,191.68 Million |
| Global CAGR (2022 - 2030) | 19.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2022-2030 |
| Segments Covered |
By Test Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Direct-To-Consumer Genetic Testing Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Direct-To-Consumer Genetic Testing Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Direct-To-Consumer Genetic Testing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:
The “Direct-To-Consumer Genetic Testing Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering the following areas:
The Direct-To-Consumer Genetic Testing market is anticipated to grow at a CAGR of 12.7% during 2024-2031.
Factors including increasing incidence of genetic disorders and rising public awareness of direct-to-consumer genetic testing are driving the Direct-To-Consumer Genetic Testing market growth.
The Direct-To-Consumer Genetic Testing market is estimated to reach US$ 4526.76 million by 2031.
Rising number of product launches is one of the future trends of the market.
23andMe, Inc.; Full Genome Corporation Inc.; Ancestry; Counsyl; Gene by Gene; Easy DNA; Helix OpCo LLC; Living DNA Ltd; Mapmygenome; and GenomeWeb are some leading players operating in the Direct-To-Consumer Genetic Testing market.
North America dominated the Direct-To-Consumer Genetic Testing market in 2023.